The Bank of England made a historic decision to cut interest rates from a 16-year high in a tight 5-4 vote by its policymakers. This move was led by Governor Andrew Bailey, who emphasized the need for cautiousness in the face of uncertainty. The reduction of rates by a quarter-point to 5% marked the first
0 Comments
Hershey’s stock saw a significant drop of 7% in premarket trading after the company’s second-quarter results fell short of analyst expectations. Despite earning $1.27 per share on revenue of $2.07 billion, the company missed the projected profit of $1.43 per share on revenue of $2.31 billion. This decline was attributed to consumers pulling back on
0 Comments
Eli Lilly’s weight loss drug Zepbound has shown promising results in patients with a common type of heart failure and obesity, based on late-stage trial data released by the company. The findings suggest that Zepbound, along with other popular GLP-1 drugs, may have health benefits beyond weight loss and blood sugar regulation. This could potentially
0 Comments
Moderna, a prominent biotech company, recently reported second-quarter revenue that exceeded expectations. However, the company decided to reduce its full-year sales guidance due to various factors such as lower expected sales in Europe, a competitive environment for respiratory vaccines in the U.S., and the potential for deferred international revenue into 2025. The company now anticipates
0 Comments
Meta, formerly known as Facebook, has been investing heavily in artificial intelligence (AI) with hopes of driving revenue growth in the future. The company’s CEO, Mark Zuckerberg, has been vocal about the positive impact AI has had on Meta’s performance in the digital advertising market. With the recent second-quarter earnings report showing better-than-expected results, it’s
0 Comments
When Donald Trump, the Republican nominee for president, received support from a portion of the tech investing world, a significant number of venture capitalists immediately rallied behind Vice President Kamala Harris, the likely Democratic nominee. Over 100 VCs joined forces to endorse Harris as she gears up for the November election. This group, known as
0 Comments
Bill Ackman’s hedge fund, Pershing Square USA, recently withdrew its plans for an initial public offering due to what appeared to be a lack of investor demand. This decision came shortly after the fund announced its intention to raise $2 billion, a significant decrease from the previously speculated $25 billion. Despite the setback, Ackman expressed
0 Comments